The month in which babies are born can affect how their immune systems develop, and even how vulnerable they are to …
MS
Study: Multiple Sclerosis Drug May Not Slow Disease Progression
Interferon beta, the most commonly prescribed drug to treat multiple sclerosis (MS), did not delay progression of the disease in relapsing patients, according to a recent study.
Jack Osbourne’s MS: After the Diagnosis
Experts say multiple sclerosis is unpredictable, but the prognosis tends to be good for patients who are diagnosed when they are young and otherwise healthy.